The expression of CD8 (the intratumoral P=0.017, the peritumoral P<0.001) in primary sites and CD3 (P=0.003) and CD4 (P=0.004) in the peritumoral primary sites were higher than that in normal breast cancer (Figure 3A). This evidence concerns the gene CD8A and breast carcinoma.